Huge advances in multiple sclerosis therapy have been underway for more than 20 years. Newer and newer immunomodulatory therapies with high efficacy are entering the market, which are positively changing the course of this disease. According to current knowledge of the pathomechanism of multiple sclerosis, it is very important to start effective treatment as early as possible, before the patient develops irreversible changes in the central nervous system. In Poland, however, access to modern therapies was severely limited for many years. Thanks to the concerted efforts of the clinician community, patient organizations and policymakers, the situation has improved very significantly in recent months. In November 2022, major changes were made to the drug program for the treatment of MS, which enabled proper, modern therapy in line with international expert recommendations.
- In recent years, the treatment paradigm for MS has changed. There is an increasingly common model of therapy around the world that relies on the use of highly effective drugs from the very be... To gain access to the complete English section of the Medexpress.pl, kindly reach out to us at [email protected].Content locked
